GlaxoSmithKline (GSK) is a world leading research-based
pharmaceutical company with a powerful combination of skills and resources
that provides a platform for delivering strong growth in today's rapidly
changing healthcare environment.
GSK's mission is to improve the quality of human life by enabling people
to do more, feel better and live longer.
Headquartered in the UK and with operations based in the US, the new
company is one of the industry leaders, with an estimated seven per cent
of the world's pharmaceutical market.
GSK also has leadership in four major therapeutic areas - anti-infectives,
central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
In addition, it is a leader in the important area of vaccines and has
a growing portfolio of oncology products.
Based on 2003 Annual Results, GSK had sales of ?1.4 billion ($35.2 billion)
and profit before tax of ?.7 billion ($11 billion). Total pharmaceutical
turnover grew 5% to just over ?8 billion ($29 billion).
GSK has over 100,000 employees worldwide. Of these, over 40,000 are in
sales and marketing, the largest sales force in the industry. Around 35,000
employees work at 85 manufacturing sites in 37 countries and over 16,000
are in R&D.
GSK R&D is based at 24 sites in seven countries. The company has a leading
position in genomics/genetics and new drug discovery technologies. The
GSK R&D budget is about ?.4bn/$4bn.